/stocks — the workspaceLOADING
All HCXY SEC filings, by type → · Earnings date & implied move · Search inside filings
HCXY is not among the 142 companies we ingest every day, so it is not in the fundamentals screener or the size and group lists built from it. This page reads its SEC filings when the page is built. Ask us to add it: we keep a count per ticker and nothing about you.
Latest report (10-Q, filed 2026-10-29). Three months to 2026-09-30 against 2025-09-30: Net income $93.6M, down 21.8% from $119.7M. Nine months to 2026-09-30 against 2025-09-30: Operating cash used $98.4M, 73.4% smaller than $370.2M. Read it line by line, each linked to its source → · Every report →
Hercules Capital, Inc. (HCXY). 6 insider Form 4 filings in the last 90 days. Next earnings confirmed for 2026-11-10 (SEC filing). Fundamentals from SEC filings; prices are end-of-day.
Every filed figure on this page is free to read, dated and sourced; no column is held back for a paid plan. Each section with figures says what date they are true as of and where they come from.
What’s behind HCXY’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Has HCXY been issuing shares? Offering history →
Volume against its own history: 63% of its last 252 sessions were lighter than the last one, the 2026-11-06 session. End-of-day bars (Databento). Volume detail
| Free cash flow per share | That year | Year before, same report | Change | Report |
|---|---|---|---|---|
| fiscal 2025 | -2.26 USD | -0.74 USD | not a growth rate (a year at or below zero) | 10-K filed 2026-02-12 |
| fiscal 2024 | -0.74 USD | 0.47 USD | not a growth rate (a year at or below zero) | 10-K filed 2025-02-13 |
| fiscal 2023 | 0.47 USD | -3.35 USD | not a growth rate (a year at or below zero) | 10-K filed 2024-02-15 |
| fiscal 2022 | -3.35 USD | 1.11 USD | not a growth rate (a year at or below zero) | 10-K filed 2023-02-16 |
Concepts read: (us-gaap:NetCashProvidedByUsedInOperatingActivities - us-gaap:PaymentsToAcquireProductiveAssets) / us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
| Diluted EPS | That year | Year before, same report | Change | Report |
|---|---|---|---|---|
| fiscal 2025 | 1.85 USD | 1.61 USD | +14.9% | 10-K filed 2026-02-12 |
| fiscal 2024 | 1.61 USD | 2.31 USD | -30.3% | 10-K filed 2025-02-13 |
| fiscal 2023 | 2.31 USD | 0.79 USD | +192.4% | 10-K filed 2024-02-15 |
| fiscal 2022 | 0.79 USD | 1.49 USD | -47.0% | 10-K filed 2023-02-16 |
Concepts read: us-gaap:EarningsPerShareDiluted
Per filed share, as each report states it. Free cash flow per share is operating cash flow less capital expenditure, over the diluted weighted average share count (or net income over diluted EPS where the count is tagged per share class).
Each year’s change comes from one annual report, which states that year and the year before on the same share basis, and the rate compounds those changes; so a split or a restatement between reports cannot bend it. A rate needs a positive figure at both ends of its window. The DCF above grows total free cash flow and divides by today’s share count, so a per-share rate also carries the buybacks or new shares of those years. These are past figures, not a forecast.
Not shown yet: the P/E range HCXY has traded at, which would set the discount rate and terminal assumptions against its own history. It needs a long daily price history we are not yet licensed to display.
No sensitivity grid: free cash flow is not positive, so the DCF gives no value at any growth or discount rate.
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from HCXY’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
Not reported in XBRL for this filer.
↓ Download the fiscal-year statement table: XLSX · CSV · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
As filed. We do not recategorize line items. Each chart plots one XBRL concept exactly as HCXY tagged it: net income us-gaap:NetIncomeLoss, EPS us-gaap:EarningsPerShareDiluted, period by period; a period the company did not tag on its own is left out, not estimated. A figure that disagrees with the filing is a bug in our extraction, not a policy, and we fix it: report a mismatch.
A plain-English read on HCXY plus an auto-SWOT, built from HCXY's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts, a bull, a bear, a risk manager, and a PM, debate HCXY using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Ask about HCXY’s revenue, earnings, valuation, filings, insiders or Congress trades. Answers come only from the numbered evidence the research brief uses, each citing the items it rests on. A question about one figure is answered by code, free. One that puts figures together is 1 generation (Pro). A question about whether to buy, sell or hold, how much, or where the price goes gets a refusal.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Closes only, split-adjusted. An average needs that many sessions on file to print. These are measurements, not support, resistance or targets. Chart with studies
Daily closes from 2024-07-01 through 2026-11-06, 508 sessions, split-adjusted. No direction, pattern, entry, target or overbought label: these are measurements. Filings dated on the move days are in HCXY’s filings; the chart with studies draws every figure.
Written by code from 508 end-of-day bars through 2026-11-06. Written by code from the data on file, not by a model. Information, not investment advice: it describes the security and recommends nothing to anyone.
This date was extracted directly from HCXY's own Form 8-K (earnings press release) filed with the U.S. Securities and Exchange Commission — not an analyst estimate or a third-party calendar. We mark a report “confirmed” only when the company itself has stated the date in a public SEC filing, and we link that filing above so you can verify it. Everything else stays an honest estimate from the company's filing cadence. From filings, not guesses.
Projected from HCXY's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentHCXY files or announces.
HCXY has rallied after 6 of its last 8 earnings reports.
Each figure is one earnings reaction — how much HCXY moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Earnings reactions have been mild.
HCXY has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+1.3% and -0.6%).
A more typical earnings reaction has been approximately ±0.2%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-10-29 | -0.1% |
| 2026-07-30 | +1.3% |
| 2026-05-05 | -0.6% |
| 2026-02-12 | +0.1% |
| 2025-10-30 | +0.2% |
| 2025-07-31 | +0.2% |
| 2025-05-01 | +0.4% |
| 2025-02-13 | +0.1% |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
On file for HCXY from Nov 9, 2026 to Nov 22, 2026: earnings date (below).
| Event | Result |
|---|---|
| Earnings date | on file. HCXY reports: Nov 10 (confirmed, sec filing; no time stated). source |
| Filing deadline | nothing in the window. Nothing in the window: the 10-K for the fiscal year ending Dec 31, 2026, due 60 days after it for a large accelerated filer, falls due Mar 1, 2027, after it. Newest periodic report on file: the 10-Q for the period ending Sep 30, 2026, filed Oct 29, 2026. filing list on EDGAR |
| Ex-dividend date | not covered. Not checked. This attestation does not cover ex-dividend dates. |
This records what these sources returned when they were read. It is not a forecast: a company can announce an event at any time, and ex-dividend dates are not covered. Window 2026-11-09 to 2026-11-22, Eastern dates. Deadlines follow SEC Rules 13a-1 and 13a-13 and Form 20-F, moved past weekends and federal holidays by Rule 0-3.
2 of the 2 checks that ran found nothing new for HCXY. 2 could not run.
Each event check looks back 30 days from the date its own source was stored, read or generated, never from the date this page was built. A check that finds nothing is a measurement of that window, not a forecast, and a check that cannot be dated does not make the claim at all.
None of the 5 estimators could run on HCXY's filings.
One estimator is a point estimate, not a range, so no band and no valuation label are published for HCXY. Below is everything that was checked, so the refusal can be read rather than taken on trust.
Nothing produced a value.
No fiscal year of price history was on record; the historical multiples need 5. No sector peer set is priced for HCXY, so sector medians could not fill the gaps.
Every refusal recorded for HCXY → · How often we decline, and why →
Free cash flow does not currently cover the dividend. That is the single most important test here, and it failing outweighs the tests that passed.
The score is passed over computable, not passed out of five. If only three tests could be run on HCXY’s filings, the score is out of three and the other two are listed with the reason they were skipped. Scoring a skipped test as a failure would punish a company for how its industry reports, and scoring it as a pass would flatter one.
Labels come from that ratio:
Below three computable tests we publish no label at all and show the individual results instead. A summary drawn from one or two tests is not a summary.
Free cash flow coverage carries the most weight in practice, because dividends are paid in cash and free cash flow is the cash actually available to pay them. The earnings payout ratio is the better-known test but the weaker one — earnings are an accounting figure, dividends are not. Where the two disagree, believe the cash.
Why tests get skipped. A REIT gets no earnings payout ratio: GAAP depreciation on appreciating property understates a REIT’s distributable earnings, which is exactly why the industry reports FFO and why REITs are required to distribute most of their taxable income. Banks and insurers get no leverage test, because deposits are debt and structurally high leverage is what a balance-sheet business is, not a warning sign.
The biggest limitation, stated plainly. The coverage tests read a single fiscal year, and one year of cash flow is far more volatile than a dividend record. A legal settlement, a tax payment or an acquisition can sink coverage in a year that says nothing about the dividend. Where a weak year contradicts a long unbroken record, we say so above rather than letting the harsher number stand alone — but you should still check what happened in that specific year.
The streak is the weakest test here, and it is deliberately listed last. Every dividend that was ever cut had an unbroken streak right up until the year it was cut. A freeze does not break the run — a company that holds its dividend flat through a bad year has not cut it — so raises are counted separately, and a long flat run cannot pass itself off as dividend growth.
Every figure above is from HCXY’s own SEC filings and the arithmetic is stated on this page. This describes what the filings show about the dividend’s coverage — it is not a prediction that the dividend will or will not be cut, not a recommendation, and not investment advice. A covered dividend can still be cut, and a strained one can still be maintained for years. Educational information only.
No SEC industry code is on file for HCXY, so it has no group to set its figures against.
Head office: San Mateo, California, United States · the company’s charter and its head office are in different states.
Source: the cover page of Hercules Capital, Inc.’s 10-Q filed 2026-10-29, on EDGAR. Filings checked 2026-11-09. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works
No tracked institution reported a position in HCXY in the latest 13F round.
No open-market Form 4 buys or sells reported for HCXY in the last ~6 months.
No lawmaker has disclosed a trade in HCXY under the STOCK Act.